Focus: Personal Genomics is a Taiwan-based biotech company specializing in next-generation sequencing (NGS) for diagnostic applications. Founded in 1999 and publicly traded, the company operates in the molecular diagnostics space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Personal Genomics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
OTC contraceptive facing imminent loss of exclusivity with no Part D data available.
Help build intelligence for Personal Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Personal Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
OTC contraceptive product nearing patent cliff with limited commercial upside.
OTC antifungal with LOE approaching; clinical efficacy established but facing generic competition.
Combination pack OTC antifungal approaching loss of exclusivity with limited differentiation.
No open positions listed yet.
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo